Total saponin of Dioscoreae hypoglaucae rhizoma ameliorates streptozotocin-induced diabetic nephropathy

被引:12
作者
Guo, Changrun [1 ]
Ding, Gang [2 ]
Huang, Wenzhe [2 ]
Wang, Zhenzhong [2 ]
Meng, Zhaoqing [1 ,2 ]
Xiao, Wei [2 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China
[2] Jiangsu Kan Pharmaceut Co Ltd, 58 Huaihai South Rd, Lianyungang 222001, Peoples R China
关键词
total saponin of Dioscoreae hypoglaucae rhizoma; diabetic nephropathy; oxidative stress; AGEs; TGF-beta; 1; ADVANCED GLYCATION ENDPRODUCTS; RENAL DAMAGE; TNF-ALPHA; RATS; ACCUMULATION; PATHWAY; INJURY; CELLS;
D O I
10.2147/DDDT.S99670
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Diabetic nephropathy has become the most common cause of morbidity and mortality in diabetic patients. Therefore, there is an urgent need for more effective and safer drugs for use in this condition. Purpose: The aims of this study were to investigate the ameliorative effects of total saponin of Dioscoreae hypoglaucae rhizoma (TSD) on diabetic nephropathy and to explore the potential underlying mechanism(s). Methods: Rats with streptozotocin-induced diabetes were orally treated with TSD at 40, 80, and 160 mg/kg/d for 12 weeks. At the end of the treatment, blood, urine, and kidneys were collected for biochemical and histological examination. Results: The results demonstrated that TSD significantly decreased the fasting blood glucose, glycosylated hemoglobin, urinary protein, serum creatinine, and blood urea nitrogen levels in diabetic rats. The results of histological examinations showed that TSD ameliorated glomerular and tubular pathological changes in diabetic rats. Furthermore, TSD significantly prevented oxidative stress and reduced the renal levels of advanced glycation end products, transforming growth factor-beta 1, connective tissue growth factor, and tumor necrosis factor-alpha. Conclusion: This study demonstrated the renoprotective effects of TSD in experimental diabetic nephropathy via a number of different mechanisms.
引用
收藏
页码:799 / 810
页数:12
相关论文
共 36 条
[1]   Advanced glycation endproducts - role in pathology of diabetic complications [J].
Ahmed, N .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (01) :3-21
[2]  
[Anonymous], GLOB DIAB PLAN 2011
[3]  
[Anonymous], [No title captured]
[4]   Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment [J].
Badal, Shawn S. ;
Danesh, Farhad R. .
DIABETES, 2015, 64 (09) :3063-3065
[5]   Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation [J].
Beisswenger, Paul J. ;
Howell, Scott K. ;
Russell, Greg ;
Miller, Michael E. ;
Rich, Stephen S. ;
Mauer, Michael .
AMINO ACIDS, 2014, 46 (02) :311-319
[6]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[7]   Protective Effects of Oxymatrine on Experimental Diabetic Nephropathy [J].
Guo, Changrun ;
Han, Fengyu ;
Zhang, Chunfeng ;
Xiao, Wei ;
Yang, Zhonglin .
PLANTA MEDICA, 2014, 80 (04) :269-276
[8]   Hydrochloride pioglitazone decreases urinary TGF-β1 excretion in type 2 diabetics [J].
Hu, Yuan-Yuan ;
Ye, Shan-Dong ;
Zhao, Li-Li ;
Zheng, Mao ;
Chen, Yan .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (07) :571-574
[9]   Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy [J].
Jones, S ;
Jones, S ;
Phillips, AO .
KIDNEY INTERNATIONAL, 2001, 59 (05) :1739-1749
[10]   Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy [J].
Kalia, K ;
Sharma, S ;
Mistry, K .
CLINICA CHIMICA ACTA, 2004, 347 (1-2) :169-176